Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/24 16:38 | 11/6/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | 4 | S.d | -3,658 | 76.82 | 0 | -48 | 107 | D | |||||||||||||||
11/7/24 16:32 | 11/6/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Parsey Merdad | CA | O | Chief Me | 6 | M.d | 7,200 | 70.14 | 0 | 103 | 102 | D | |||||||||||||||
11/7/24 16:32 | 11/6/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Parsey Merdad | CA | O | Chief Me | 6 | S.d | -7,200 | 70.14 | 0 | -103 | 102 | D | |||||||||||||||
10/28/24 15:09 | 10/25/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Telman Deborah H | CA | O | EVP,Corp | 2 | M.d | 0 | 0.00 | 0 | 1 | 6 | 21 | D | ||||||||||||||
9/11/24 19:38 | 9/10/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Patterson Sandra | CA | O | SVP,Cont | 1 | M.d | 0 | 0.00 | 0 | 1 | 3 | 37 | D | ||||||||||||||
9/11/24 19:30 | 9/10/24 | GILD | Health | BioPrd | Biological Products, (No Diag | O'Day Daniel Patrick | CA | DO | CB,CEO | 1 | M.d | 0 | 0.00 | 0 | 10 | 2 | 496 | D | ||||||||||||||
9/11/24 19:20 | 9/10/24 | GILD | Health | BioPrd | Biological Products, (No Diag | Dickinson Andrew D | CA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 4 | 3 | 139 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |